Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
The multiple facets of mTOR in immunity
Trends in Immunology, 10/08/09
Weichhart T et al. – The results place mTOR in a novel immunoregulatory context that highlights the potential of mTOR inhibitors as both immunosuppressant and anti–cancer agents.
Related Articles
Targeting the mTOR Pathway in Neuroendocrine Tumors
Clinical Journal of Oncology Nursing, 10/07/09
Relevance Score: 91%
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Journal of Hematology & Oncology, 10/30/09
Relevance Score: 90%
Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression
Pediatric Nephrology, 11/04/09
Relevance Score: 87%
The Role of the Mammalian Target Of Rapamycin (mTOR) in Renal Disease
Journal of the American Society of Nephrology, 11/04/09
Relevance Score: 87%
Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor gamma Agonists. Requirement for mTOR/Akt2 in PPAR-gamma Activation
Circulation Research, 10/02/09
Relevance Score: 84%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation
Immunology & Cell Biology, 12/08/09
The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
Cancer Treatment Reviews, 12/07/09
Small-for-size liver graft injury--impact on tumor behavior
Transplantation Reviews, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


